Article

jdsupra.com on 2020-10-01 00:58

OIG Advisory Opinion Rejects Pharmaceutical Manufacturer’s Proposed Beneficiary Cost-Sharing Program

On September 18, 2020, the Department of Health and Human Services Office of Inspector General (OIG) issued an unfavorable Advisory Opinion, No. 20-05 ...

Related news

OIG Issues Advisory Opinion Giving the Green Light to a Pharmaceutical Manufacturer’s Plan to Provide Limited Functionality Smartphones to Financially Needy Patients for Adherence Data Monitoring jdsupra.com
California , Switzerland , Spalding , United States
OIG Issues Advisory Opinion for Pharmaceutical Manufacturer’s Cost-Sharing Assistance Proposal jdsupra.com
OIG Approves Pharmaceutical Manufacturer’s Loaning of Smartphones to Support Digital Medicine (DM)jdsupra.com
California , United States , Switzerland
OIG Issues Favorable Advisory Opinion Regarding Free Drug Provided by Pharmaceutical Manufacturer to Patients jdsupra.com
United States
OIG Greenlights Manufacturer’s Limited Free Drug Program jdsupra.com
United States
OIG Advisory Opinion Allows Charitable Pediatric Clinic to Provide Routine Cost-Sharing Waivers jdsupra.com
California , United States , Switzerland
OIG Allows Cost-Sharing Waivers Among Fire Departments for Ambulance Services in Advisory Opinion 18-08 jdsupra.com
California , United States , Switzerland
OIG Advisory Opinion Allows Routine Waiver of Federal Cost-Sharing Obligations jdsupra.com
California , United States , Switzerland
OIG Approves Charitable Pediatric Clinic's Cost-Sharing Waivers in Advisory Opinion 19-01 jdsupra.com
California , United States , Switzerland
OIG Advisory Opinion Permits a Pharmaceutical Manufacturer to Provide Financial Assistance to Needy Patients Receiving Risky Cell Therapy jdsupra.com
California , United States , Switzerland
OIG Issues Advisory Opinion Regarding Pharmaceutical Companies’ Proposed Arrangement to Provide Cost-Sharing Subsidies jdsupra.com
OIG Advisory Opinion No. 19-02 Allows Pharmaceutical Manufacturer to Temporarily Loan Smartphones to Financially Needy Patients to Receive Data from a Digestible Medication Sensor jdsupra.com
California , Switzerland , United States
HHS-OIG: Pharma Manufacturer’s Proposed Copayment Assistance Program ‘Highly Suspect’ Under Federal Anti-Kickback Statute jdsupra.com
Reg , United States
Blog: OIG Provides Strong Rebuke of Pharmaceutical Free Drug Program jdsupra.com
California , United States , Switzerland
OIG Issues Favorable Opinion for Pharmaceutical Manufacturer's Free Drug Program jdsupra.com
Reg
OIG Nixes Pharmaceutical Cost-Sharing Subsidy Program Under AKS jdsupra.com
OIG Issues Advisory Opinion Approving Biopharmaceutical Manufacturer’s Sponsorship of Free Genetic Testing and Counseling jdsupra.com
OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trial jdsupra.com
OIG Declines to Impose Sanctions Against Device Manufacturer’s Medicare Cost-Sharing Subsidy in Clinical Trial jdsupra.com
OIG Issues Request for Information Regarding the Anti-Kickback Statute and Beneficiary Inducements Civil Monetary Penalty jdsupra.com
California , United States , Switzerland